@sabuss in News·a year ago

Viking Therapeutics Announces Pricing of $250 Million Public Offering of Common Stock

/PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (Nasdaq: VKTX), a clinical-stage biopharmaceutical company focused

viking-therapeutics-announces-pricing-of-usd250-million-public-offering-of-common-stock

1

0.0075 TMAC

Ask TipMeACoffee AI